Video

Dr. Perez on her Anticipated Results for ASCO and SABCS

Author(s):

Edith A. Perez, MD,

In Partnership With:

Edith A. Perez, MD, Director of Breast Program and Professor of Medicine, Mayo Clinic on her Anticipated Results for ASCO and SABCS

Related Videos
Ashkan Emadi, MD, PhD
Alexis LeVee, MD
Martin Dreyling, MD
Tom van Meerten, MD, PhD, hematologist, Department of Hematology, University Medical Center Groningen
John H. Strickler, MD
Junjie Li, MD
Peter Riedell, MD
Jorge Cortes, MD
2 experts are featured in this series.
Related Content
Kelly K. Hunt, MD, FACS, FSSO, of MD Anderson Cancer Center
January 3rd 2025

One Surgeon’s Spirit and Brilliance Lift a Whole Community

MedNews Week
January 1st 2025

DESTINY-Breast06 Data Demonstrate the Role of T-DXd in HER2-Low and -Ultralow Breast Cancer: With Chandler Park, MD; and Guiseppe Curigliano, MD, PhD

Rafael Fonseca, MD
December 30th 2024

Working on the Frontlines of a Revolution in Multiple Myeloma Care

OncLive On Air
September 11th 2024

Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress

Joseph A. Sparano, MD, FACP
December 23rd 2024

Tailor-Made for a Lifelong Pursuit of Precision in Cancer Care

Lasofoxifene in Breast Cancer | Image Credit: © Sebastian Kaulitzki – stock.adobe.com
December 19th 2024

Lasofoxifene Aims to Amplify Efficacy of Abemaciclib in ESR1-Mutated ER+/HER2– Metastatic Breast Cancer